Since 2001, HJFMRI has been working throughout sub-Saharan Africa, building human research capacity, executing clinical trials and conducting disease surveillance for HIV, antimicrobial and malaria drug resistance, Ebola, influenza, enteric pathogens, acute febrile illness, Lassa fever, vector-borne illnesses, and other infectious diseases. HJFMRI is a key collaborator for the Child Health and Mortality Prevention Surveillance Network (CHAMPS) and DoD’s Global Emerging Infections Surveillance (GEIS). In collaboration with WRAIR, HJFMRI participates in NIH-funded clinical research networks (HVTN, ACTG and CoVPN), also implements high-impact, comprehensive HIV prevention, care and treatment programs under PEPFAR in four African countries. HJFMRI also supports a strategic Army-Navy initiative called the Joint West Africa Research Group (JWARG) in Nigeria, Liberia and Ghana.
HJFMRI extended its geographic reach to Jordan in 2016 to support the Walter Reed Army Institute of Research (WRAIR) in establishing the Partnership for Research in the Middle East (PRIME). This initiative, led by WRAIR’s Emerging Infectious Diseases Branch (EIDB), includes collaboration with the Jordanian Royal Medical Services and the Jordan Ministry of Health focused on training and improving bio preparedness with the intention of studying emerging infectious diseases in the region. Site development and training activities are ongoing.
DoD infectious diseases research funding awarded to the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), HJFMRI’s parent, is expanding in Europe. Led by the US Military HIV Research Program (MHRP), HJF supports a collaboration with the Institute for HIV Research at the University of Bonn to conduct cohort studies for HIV and related infections in Germany and determine the feasibility of conducting an HIV vaccine efficacy trial there in the future. In 2022, HJF partnered with the incumbent, TMC Global Professional Services, to win a newly awarded DoD surveillance contract in support of the US Medical Research Directorate-Georgia (MRD-G), an overseas branch of WRAIR, based out of the Richard Lugar Center for Public Health Research in Tbilisi, Georgia. HJFMRI’s presence in Georgia ensures expansion of this work is possible via direct in country capacity and serves as a platform from which to execute additional research throughout the continent.
Registered in Peru, HJFMRI is strategically positioned to support infectious disease research throughout the continent to include work being executed by its parent company, HJF. Currently, observational studies of sepsis in Peru, through a collaboration between HJF’s ACESO program and NAMRU-6, have been initiated to advance tools and strategies to improve sepsis outcomes in low resource settings and test molecular POC diagnostic platforms for evaluation in real-world scenarios, critical for ensuring the health of deployed US military service personnel and the global community.
HJF has a long-standing relationship with MHRP and the Division of Retrovirology at AFRIMS in Bangkok conducting HIV vaccine and remission research. HJFMRI has been registered in Cambodia since 2018 to ensure rapid response in support of HJF’s ACESO program and ongoing research in country with NAMRU-2 on sepsis.Additional registrations are under consideration, such as in the Philippines and Malaysia, where HJF is already executing, to increase capacity of HJFMRI to better meet emerging stakeholder requirements throughout the region.